Surgery News and Research

RSS

Selenium fails to protect NSCLC patients against second primary tumors

Selenium supplementation does not reduce the risk for second primary tumors in patients with resected non–small-cell lung cancer, researchers say.

17 Dec 2013

First Edition: December 17, 2013

Today's headlines include reports about how the health law is viewed by immigrant populations.

17 Dec 2013

Paragonix Technologies files FDA Pre-Marketing Notification Application for Sherpa Pak Transporter

Paragonix Technologies, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration for its Sherpa Pak Transporter. The Sherpa Pak Transporter is indicated for the static hypothermic preservation of kidneys during transportation and eventual transplantation into a recipient, using cold storage solutions indicated for use with the kidney.

17 Dec 2013

Neuro-Oncology publishes promising phase 2 results from Agenus’ brain cancer vaccine study

Agenus Inc., a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, today announced results published from a Phase 2 study demonstrated that more than 90% of the patients treated with Prophage Series G-200 were alive at six months after surgery and 30% were alive at twelve months.

17 Dec 2013

Research finds link between opioid-sparing technique and reduced progression of prostate cancer

The methods used to anesthetize prostate cancer patients and control pain when their prostate glands are surgically removed for adenocarcinoma may affect their long-term cancer outcomes, a study led by Mayo Clinic has found. Opioids, painkillers commonly given during and after surgery, may suppress the immune system's ability to fight cancer cells.

17 Dec 2013

Affordable Care Act may help strengthen trauma systems

Traumatic injuries are the leading cause of death and disability for people under the age of 45 and the fourth-leading cause of death for people of all ages. Much progress has been made over the last 50 years in developing statewide regionalized trauma systems to care for these injuries, but authors of a review appearing in the December issue of Health Affairs, believe more work is needed to ensure the right patient gets to the right place at the right time, and that the Affordable Care Act may offer opportunities to strengthen trauma systems.

17 Dec 2013

Less than 15% of residency programs teach new physicians to practice cost-conscious care

Despite a national consensus among policy makers and educators to train residents to be more conscious of the cost of care, less than 15 percent of internal medicine residency programs have a formal curriculum addressing it, a new research letter published today in JAMA Internal Medicine by a Penn Medicine physician found.

17 Dec 2013

St. Joseph's Children's Hospital opens new Steinbrenner Children's Emergency/Trauma Center

St. Joseph's Children's Hospital in Tampa opened its new and expanded Steinbrenner Children's Emergency/Trauma Center Dec. 16, 2013. The hospital has the busiest children's emergency center in the region, and the larger, advanced facility will increase the community's access to the highest level of pediatric emergency care in the area.

16 Dec 2013

Study: Blue light proves to have powerful bacteria-killing ability

Blue light has proven to have powerful bacteria-killing ability in the laboratory. The potent antibacterial effects of irradiation using light in the blue spectra have now also been demonstrated in human and animal tissues. A series of groundbreaking articles that provide compelling evidence of this effect are published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.

16 Dec 2013

Potential dual benefits to tackling LUTS progression risk factors

Research shows that several risk factors associated with Type 2 diabetes and cardiovascular disease also predict the progression of storage and voiding lower urinary tract symptoms in men, suggesting that targeting these could have multiple benefits.

16 Dec 2013

Incision technique shows potential for bladder neck contracture

A US team reports that deep lateral transurethral incisions are a promising technique for the treatment of recurrent bladder neck contracture in men following prostate surgery.

16 Dec 2013

Chest wall resection effective for recurrent mesothelioma

Salvage chest wall resection could lengthen survival in patients with isolated chest wall recurrence of malignant pleural mesothelioma, research indicates.

16 Dec 2013

Glioblastoma multiforme patients treated with experimental vaccine show improved survival

Patients with recurrent glioblastoma multiforme treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine that was recently published in the journal Neuro-Oncology and accompanied by an editorial highlighting the importance of the trial.

16 Dec 2013

Experimental drug that targets macrophages decreases cancer's growth

An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.

16 Dec 2013

New classification system to manage emergency surgery described in special issue of BJS

Researchers in Finland have implemented a classification system for emergency operations that allows for a fair and efficient way to manage a large volume of such surgery.

16 Dec 2013

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.

16 Dec 2013

Robotic trolley system helps overcome falling fear for patients who recovering from stroke, brain injury

The risk and fear of falling often affects patients who are recovering from a stroke, spinal cord or brain injury, and orthopaedic injuries, and that fear may inhibit their progress in rehabilitation.

16 Dec 2013

Duke research team develops better recipe for synthetic replacement cartilage in joints

A Duke research team has developed a better recipe for synthetic replacement cartilage in joints.

16 Dec 2013

Adding drug to presurgery chemotherapy improves results for women with triple-negative breast cancer

The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.

16 Dec 2013

HCA renews contract with Florida Blue

Florida Blue and HCA announced today a contract renewal that ensures Florida Blue members will continue to have access to high quality care at HCA's 42 hospitals and 32 surgery centers throughout Florida.

16 Dec 2013

Surgery News and Research

Selenium fails to protect NSCLC patients against second primary tumors

First Edition: December 17, 2013

Paragonix Technologies files FDA Pre-Marketing Notification Application for Sherpa Pak Transporter

Neuro-Oncology publishes promising phase 2 results from Agenus’ brain cancer vaccine study

Research finds link between opioid-sparing technique and reduced progression of prostate cancer

Affordable Care Act may help strengthen trauma systems

Less than 15% of residency programs teach new physicians to practice cost-conscious care

St. Joseph's Children's Hospital opens new Steinbrenner Children's Emergency/Trauma Center

Study: Blue light proves to have powerful bacteria-killing ability

Potential dual benefits to tackling LUTS progression risk factors

Incision technique shows potential for bladder neck contracture

Chest wall resection effective for recurrent mesothelioma

Glioblastoma multiforme patients treated with experimental vaccine show improved survival

Experimental drug that targets macrophages decreases cancer's growth

New classification system to manage emergency surgery described in special issue of BJS

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Robotic trolley system helps overcome falling fear for patients who recovering from stroke, brain injury

Duke research team develops better recipe for synthetic replacement cartilage in joints

Adding drug to presurgery chemotherapy improves results for women with triple-negative breast cancer

HCA renews contract with Florida Blue

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News